These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33359614)

  • 1. Analytical and clinical evaluation of four commercial SARS-CoV-2 serological immunoassays in hospitalized patients and ambulatory individuals.
    Catry E; Jacqmin H; Dodemont M; Saad Albichr I; Lardinois B; de Fays B; Delaere B; Closset M; Laurent T; Denis O; Galanti L; Mullier F; Huang TD
    J Virol Methods; 2021 Mar; 289():114060. PubMed ID: 33359614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories.
    Harritshøj LH; Gybel-Brask M; Afzal S; Kamstrup PR; Jørgensen CS; Thomsen MK; Hilsted L; Friis-Hansen L; Szecsi PB; Pedersen L; Nielsen L; Hansen CB; Garred P; Korsholm TL; Mikkelsen S; Nielsen KO; Møller BK; Hansen AT; Iversen KK; Nielsen PB; Hasselbalch RB; Fogh K; Norsk JB; Kristensen JH; Schønning K; Kirkby NS; Nielsen ACY; Landsy LH; Loftager M; Holm DK; Nilsson AC; Sækmose SG; Grum-Schwensen B; Aagaard B; Jensen TG; Nielsen DM; Ullum H; Dessau RB
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33574119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection.
    Chua KYL; Vogrin S; Bittar I; Horvath JH; Wimaleswaran H; Trubiano JA; Holmes NE; Lam Q
    Pathology; 2020 Dec; 52(7):778-782. PubMed ID: 33039094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays.
    Kubota K; Kitagawa Y; Matsuoka M; Imai K; Orihara Y; Kawamura R; Sakai J; Ishibashi N; Tarumoto N; Takeuchi S; Maesaki S; Maeda T
    Diagn Microbiol Infect Dis; 2021 Jul; 100(3):115370. PubMed ID: 33744623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
    Harley K; Gunsolus IL
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An original multiplex method to assess five different SARS-CoV-2 antibodies.
    Favresse J; Brauner J; Bodart N; Vigneron A; Roisin S; Melchionda S; Douxfils J; Ocmant A
    Clin Chem Lab Med; 2021 Apr; 59(5):971-978. PubMed ID: 33554567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort.
    Davidson N; Evans J; Giammichele D; Powell H; Hobson P; Teis B; Glover H; Guppy-Coles KB; Robson J
    Pathology; 2020 Dec; 52(7):764-769. PubMed ID: 33070955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19.
    Chamkhi S; Dhaouadi T; Sfar I; Mokni S; Jebri A; Mansouri D; Ghedira S; Ben Jemia E; Ben Boujemaa S; Houissa M; Aouina H; Ben Abdallah T; Gorgi Y
    Int J Immunopathol Pharmacol; 2022; 36():20587384211073232. PubMed ID: 35113728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and performance comparison of three SARS-CoV-2 antibody assays.
    Paiva KJ; Grisson RD; Chan PA; Huard RC; Caliendo AM; Lonks JR; King E; Tang EW; Pytel-Parenteau DL; Nam GH; Yakirevich E; Lu S
    J Med Virol; 2021 Feb; 93(2):916-923. PubMed ID: 32710669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection.
    Chew KL; Tan SS; Saw S; Pajarillaga A; Zaine S; Khoo C; Wang W; Tambyah P; Jureen R; Sethi SK
    Clin Microbiol Infect; 2020 Sep; 26(9):1256.e9-1256.e11. PubMed ID: 32531475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
    Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N
    J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers.
    Mullins KE; Merrill V; Ward M; King B; Rock P; Caswell M; Ahlman M; Harris AD; Christenson R
    Clin Biochem; 2021 Apr; 90():23-27. PubMed ID: 33472036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four high-throughput, automated immunoassays for the detection of SARS-CoV-2 antibodies.
    Oakey J; Haslam S; Brown A; Eglin J; Houghton B; Singleton D
    Ann Clin Biochem; 2021 Sep; 58(5):487-495. PubMed ID: 33892600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance of the Elecsys® anti-SARS-CoV-2 combined in an algorithm with two specific anti-IgG immunoassays for the evaluation of the serological response of patients with COVID-19 in a population with a high prevalence of infection.
    Gabaldó-Barrios X; Iftimie S; Hernández-Aguilera A; Pujol I; Ballester F; Fernández L; Cladellas S; Castro A; Joven J; Camps J; Simó JM
    Ann Clin Biochem; 2021 Nov; 58(6):614-621. PubMed ID: 34325536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
    Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
    J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of six immunoassays for the detection of antibodies against SARS-CoV-2.
    Pérez-García F; Pérez-Tanoira R; Iglesias ME; Romanyk J; Arroyo T; Gómez-Herruz P; González R; Lapeña García S; Cuadros-González J
    J Virol Methods; 2021 Mar; 289():114047. PubMed ID: 33338544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain.
    Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K
    J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.